Physician profile
Hai Xu
NPI 1093133878
$24,975.07
in general payments reported to CMS, 2019-2025
21 companies · $5,412 in 2025
The $5,412 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.44 · 2022: $436 · 2023: $522 · 2024: $19K · 2025: $5,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Food and Beverage: $5,972 · Grant: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,487.14 |
| Food and Beverage | $5,972.23 |
| Grant | $1,063.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13,135.13 | 2021-2025 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided, (7881) US Und |
| Abbott Laboratories | $5,227.01 | 2022-2025 | Perclose Proglide, Optis, Perclose Prostyle |
| Boston Scientific Corporation | $4,278.63 | 2023-2025 | Avvigo Guidance System, Sentinel, Jetstream Sc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.91 | 2023-2024 | Jardiance |
| Abiomed | $377.40 | 2023-2025 | Impella |
| Medtronic, INC. | $352.43 | 2022-2024 | Symplicity G3, Onyx Frontier, Ffrangio |
| Stryker Corporation | $221.86 | 2025 | Flowtriever |
| Novartis Pharmaceuticals Corporation | $173.39 | 2022-2025 | |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $124.96 | 2022 | |
| Inari Medical, INC. | $122.18 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $89.24 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $75.68 | 2025 | Camzyos |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $42.33 | 2025 | Uptravi, Opsumit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $34.42 | 2025 | Stratafix |
| Irhythm Technologies, INC. | $30.11 | 2024 | Zio Monitor, Zio Xt Patch |
| Biotronik INC. | $28.36 | 2022 | |
| Teleflex LLC | $22.82 | 2023 | Guideliner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.85 | 2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $17.85 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hai Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.